These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 6657927

  • 41. The radiosensitizing effects of misonidazole (MISO) in combination with diethyl maleate (DEM) in mouse mammary tumors.
    Ono K, Komuro C, Nishidai T, Shibamoto Y, Dodo Y, Takahashi M, Abe M, Shrieve DC.
    Int J Radiat Oncol Biol Phys; 1986 Oct; 12(10):1843-7. PubMed ID: 3759535
    [Abstract] [Full Text] [Related]

  • 42. Tumour-specific enhancement of thermoradiotherapy at mild temperatures by the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid.
    Murata R, Horsman MR.
    Int J Hyperthermia; 2004 Jun; 20(4):393-404. PubMed ID: 15204520
    [Abstract] [Full Text] [Related]

  • 43. Comparison of hyperbaric oxygen and misonidazole in fractionated irradiation of murine tumors.
    Suit HD, Maimonis P, Michaels HB, Sedlacek R.
    Radiat Res; 1981 Aug; 87(2):360-7. PubMed ID: 7268001
    [No Abstract] [Full Text] [Related]

  • 44. Enhancement of artificial lung metastases by misonidazole.
    Rockwell S, Nierenburg M, Irvin CG.
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1395-8. PubMed ID: 6469763
    [Abstract] [Full Text] [Related]

  • 45. Tumor eradication and cell survival after localized hyperthermia induced by ultrasound.
    Marmor JB, Hilerio FJ, Hahn GM.
    Cancer Res; 1979 Jun; 39(6 Pt 1):2166-71. PubMed ID: 445414
    [Abstract] [Full Text] [Related]

  • 46. [The radiosensitizing effects of misonidazole and/or 5FU on C3H mouse mammary carcinoma].
    Hasegawa R.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1985 Sep 25; 45(9):1270-7. PubMed ID: 4094894
    [No Abstract] [Full Text] [Related]

  • 47. Treatment of mouse mammary tumors using combined hyperthermia and ischemia.
    Baker GM, Wright EA.
    Cancer Res; 1983 Jul 25; 43(7):3392-7. PubMed ID: 6850644
    [Abstract] [Full Text] [Related]

  • 48. In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: methotrexate, 5-fluorouracil and adriamycin.
    Tannock IF.
    Br J Cancer; 1980 Dec 25; 42(6):861-70. PubMed ID: 7459220
    [Abstract] [Full Text] [Related]

  • 49. Development of thermotolerance during fractionated hyperthermia in a solid tumor in vivo.
    Kamura T, Nielsen OS, Overgaard J, Andersen AH.
    Cancer Res; 1982 May 25; 42(5):1744-8. PubMed ID: 7066896
    [Abstract] [Full Text] [Related]

  • 50. Enhancement of misonidazole chemopotentiation by mild hyperthermia (41 degrees C) in vitro and selective enhancement in vivo.
    Mulcahy RT, Gipp JJ, Tanner MA.
    Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Jul 25; 52(1):57-65. PubMed ID: 3496311
    [Abstract] [Full Text] [Related]

  • 51. Capillary blood flow in murine tumors, feet, and intestines during localized hyperthermia.
    Peck JW, Gibbs FA.
    Radiat Res; 1983 Oct 25; 96(1):65-81. PubMed ID: 6622656
    [Abstract] [Full Text] [Related]

  • 52. In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: cyclophosphamide and BCNU.
    Tannock IF.
    Br J Cancer; 1980 Dec 25; 42(6):871-80. PubMed ID: 7459221
    [Abstract] [Full Text] [Related]

  • 53. Misonidazole neurotoxicity in mice decreased by administration with pyridoxine.
    Eifel PJ, Brown DM, Lee WW, Brown JM.
    Int J Radiat Oncol Biol Phys; 1983 Oct 25; 9(10):1513-9. PubMed ID: 6629891
    [Abstract] [Full Text] [Related]

  • 54. The effects of misonidazole during continuous low dose rate irradiation.
    Fu KK, Hurst S, Begg AC, Brown JM.
    Cancer Clin Trials; 1980 Oct 25; 3(3):257-65. PubMed ID: 7438323
    [Abstract] [Full Text] [Related]

  • 55. The therapeutic potential of misonidazole enhancement of alkylating agent cytotoxicity.
    Hirst DG, Brown JM.
    Int J Radiat Oncol Biol Phys; 1982 Oct 25; 8(3-4):639-42. PubMed ID: 7107389
    [Abstract] [Full Text] [Related]

  • 56. Change in the in vivo hyperthermic response resulting from the metabolic effects of temporary vascular occlusion.
    Stewart JR, Gibbs FA, Lehman CM, Peck JW, Egger MJ.
    Int J Radiat Oncol Biol Phys; 1983 Feb 25; 9(2):197-201. PubMed ID: 6833023
    [Abstract] [Full Text] [Related]

  • 57. [Combined effects of gamma rays, cis-diamminedichloroplatinum (CDDP) and systemic hyperthermia mastocytoma transplanted into muscle in the mouse].
    Nakamura W, Komatsu K, Kageyama K.
    C R Seances Soc Biol Fil; 1985 Feb 25; 179(4):558-62. PubMed ID: 2938683
    [Abstract] [Full Text] [Related]

  • 58. Tumor oxygenation after mild-temperature hyperthermia in combination with carbogen breathing: dependence on heat dose and tumor type.
    Okajima K, Griffin RJ, Iwata K, Shakil A, Song CW.
    Radiat Res; 1998 Mar 25; 149(3):294-9. PubMed ID: 9496893
    [Abstract] [Full Text] [Related]

  • 59. Regional measurements of [14C]misonidazole distribution and blood flow in subcutaneous RT-9 experimental tumors.
    Blasberg R, Horowitz M, Strong J, Molnar P, Patlak C, Owens E, Fenstermacher J.
    Cancer Res; 1985 Apr 25; 45(4):1692-701. PubMed ID: 3978636
    [Abstract] [Full Text] [Related]

  • 60. Changes in misonidazole binding with hypoxic fraction in mouse tumors.
    Hirst DG, Hazlehurst JL, Brown JM.
    Int J Radiat Oncol Biol Phys; 1985 Jul 25; 11(7):1349-55. PubMed ID: 4008291
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.